Medication info
Telcadiplus Tablets 80/12.5 mg

Telcadiplus Tablets 80/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
White or off-white, oblong tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201906467 · Approved 2019.09.17 · Insurance code 640903900

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each ingredient, it is recommended that the dose of each ingredient be adjusted individually according to the patient’s needs. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - Telmisartan/hydrochlorothiazide 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - Telmisartan/hydrochlorothiazide 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - Telmisartan/hydrochlorothiazide 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered concomitantly as single-agent products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. The dose should not exceed 40/12.5mg once daily. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dosage adjustment is necessary.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medication is used to treat essential hypertension. It is particularly administered as an additional treatment when blood pressure is not sufficiently controlled with telmisartan alone, helping to effectively lower blood pressure. This reduces the risk of complications associated with hypertension and improves the overall health status of the patient.

How to take

Adult dose

Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each ingredient, it is recommended that the dose of each ingredient be adjusted individually according to the patient’s needs. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - Telmisartan/hydrochlorothiazide 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - Telmisartan/hydrochlorothiazide 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - Telmisartan/hydrochlorothiazide 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered concomitantly as single-agent products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. The dose should not exceed 40/12.5mg once daily. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dosage adjustment is necessary.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication should not be used during pregnancy, particularly in the second and third trimesters, as it may cause serious harm to the fetus. If pregnancy is confirmed, discontinue use immediately and consult a physician. This medication should not be administered to patients with specific allergies or severe impairment of liver and kidney function. Additionally, patients with bile duct obstruction or cholestasis should avoid taking this medication. Elderly patients or those with elevated potassium levels or impaired liver function should use this medication with caution. Care should also be taken in patients with heart or vascular diseases to prevent excessively low blood pressure. This medication may increase the risk of skin cancer, so sun exposure should be avoided and skin conditions should be checked regularly. Patients should carefully observe for side effects such as dizziness, low blood pressure, and electrolyte imbalances while taking this medication. Regular blood tests are needed due to the risk of potassium levels becoming too high or low. This medication may interact with other antihypertensive drugs, certain diuretics, lithium, and non-steroidal anti-inflammatory drugs, so it is essential to inform your physician of any other medications being taken. Caution should be exercised while driving or operating machinery as dizziness or drowsiness may occur. In case of overdose, symptoms such as low blood pressure, electrolyte imbalances, and dehydration may appear, so immediate medical attention should be sought. Safety and efficacy have not been established for children under 18 years of age. This medication should be kept out of reach of children and not transferred to another container.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 111 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pulmonary inflammation
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • abnormal liver function
  • liver disorders
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasms
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased serum uric acid
  • increased serum creatinine
  • increased creatine phosphokinase
  • increased liver enzymes
  • upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • eczema
  • drug rash
  • toxic skin rash
  • bone pain
  • renal impairment
  • weakness
  • increased creatine phosphokinase
  • decreased hemoglobin
  • purpura with thrombocytopenia
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenia
  • hypomagnesemia
  • hyperglycemia
  • hypercalcemia
  • hypochloremic alkalosis
  • necrotizing vasculitis
  • acute respiratory distress syndrome
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • weakness
  • fever
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremor
  • facial flushing
  • malaise
  • fatigue
  • weight loss
  • proteinuria
  • itching
  • myalgia
  • sense of unreality
  • lip and hand tremors
  • sensory hypersensitivity
  • decreased vision
  • hypotension
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture exposure, ideally at a temperature between 1 and 30 degrees Celsius. This helps to maintain the medication's effectiveness.

Appearance and packaging

Appearance

White or off-white, oblong tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.